Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination.
作者信息
Franco-Paredes Carlos, Suarez Jose Antonio, Henao-Martínez Andrés F
机构信息
Department of Medicine, Division of Infectious Diseases, University of Colorado Denver School of Medicine, Anschutz Medical Campus, 12700 East 19th Avenue, 11C01, Aurora, CO 80045, United States; and Hospital Infantil de Mexico, Federico Gomez, Mexico City, Mexico 06720.
Investigador SNI Senacyt Panamá, Clinical Research Department, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá City, Panama.
出版信息
Int J Infect Dis. 2021 Apr;105:243-244. doi: 10.1016/j.ijid.2021.02.061. Epub 2021 Feb 26.
Abstract
摘要
相似文献
1
Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination.全球新冠疫苗公平性应先于要求旅行者提供疫苗接种证明。
Int J Infect Dis. 2021 Apr;105:243-244. doi: 10.1016/j.ijid.2021.02.061. Epub 2021 Feb 26.
2
Failure to achieve global vaccine equity will have dire consequences.无法实现全球疫苗公平分配将产生严重后果。
BMJ. 2021 Mar 19;372:n712. doi: 10.1136/bmj.n712.
3
The International Health Regulations (2005) and the re-establishment of international travel amidst the COVID-19 pandemic.《国际卫生条例（2005）》与 COVID-19 大流行期间国际旅行的恢复
J Travel Med. 2020 Dec 23;27(8). doi: 10.1093/jtm/taaa127.
4
Travel vaccines throughout history.旅行疫苗的历史。
Travel Med Infect Dis. 2022 Mar-Apr;46:102278. doi: 10.1016/j.tmaid.2022.102278. Epub 2022 Feb 12.
5
Covid-19 vaccine passports: access, equity, and ethics.新冠疫苗通行证：准入、公平性与伦理道德
BMJ. 2021 Apr 1;373:n861. doi: 10.1136/bmj.n861.
6
Intention to Take COVID-19 Vaccine as a Precondition for International Travel: Application of Extended Norm-Activation Model.国际旅行前接种 COVID-19 疫苗的意向：扩展规范激活模型的应用。
Int J Environ Res Public Health. 2021 Mar 17;18(6):3104. doi: 10.3390/ijerph18063104.
7
Soft Law Possibilities in Global Health Law.全球卫生法中的软法可能性
J Law Med Ethics. 2021;49(1):152-155. doi: 10.1017/jme.2021.20.
8
COVID-19 air travel restrictions and vaccine passports: An ongoing debate.新冠疫情航空旅行限制与疫苗护照：一场持续的辩论。
Travel Med Infect Dis. 2021 Jul-Aug;42:102049. doi: 10.1016/j.tmaid.2021.102049. Epub 2021 Apr 20.
9
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
10
Solidarity in the wake of COVID-19: reimagining the International Health Regulations.新冠疫情后的团结：重新构想《国际卫生条例》
Lancet. 2020 Jul 11;396(10244):82-83. doi: 10.1016/S0140-6736(20)31417-3. Epub 2020 Jun 19.
引用本文的文献
1
Bringing Generalists to Global Health: a Missed Opportunity and Call to Action.将通才引入全球健康领域：错失的机会与行动呼吁。
J Gen Intern Med. 2024 Aug;39(10):1901-1904. doi: 10.1007/s11606-023-08573-x. Epub 2023 Dec 22.
2
Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic.新冠疫情下的旅行：全球大流行期间国际旅行健康综述
Curr Infect Dis Rep. 2022;24(10):129-145. doi: 10.1007/s11908-022-00784-3. Epub 2022 Aug 4.
3
The Vaccination Process against the COVID-19: Opportunities, Problems and Support.针对新冠病毒的疫苗接种过程：机遇、问题与支持
Healthcare (Basel). 2021 Sep 6;9(9):1165. doi: 10.3390/healthcare9091165.
4
Epidemiological Study of COVID-19 Fatalities and Vaccine Uptake: Insight From a Public Health Database in Ontario, Canada.COVID-19死亡病例与疫苗接种情况的流行病学研究：来自加拿大安大略省一个公共卫生数据库的见解
Cureus. 2021 Jul 4;13(7):e16160. doi: 10.7759/cureus.16160. eCollection 2021 Jul.
5
COVID-19 Pandemic and Equal Access to Vaccines.新冠疫情与疫苗的平等可及性
Vaccines (Basel). 2021 May 21;9(6):538. doi: 10.3390/vaccines9060538.
本文引用的文献
1
COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis.《国际卫生条例》下的新冠疫苗——我们必须使用世界卫生组织国际预防接种或预防措施证书。
Int J Infect Dis. 2021 Mar;104:175-177. doi: 10.1016/j.ijid.2021.01.039. Epub 2021 Jan 20.
2
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
3
Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access.新冠疫苗全球获取机制（Covax）必须超越新冠疫苗的按比例分配，以确保公平和平等的获取。
BMJ. 2021 Jan 5;372:m4853. doi: 10.1136/bmj.m4853.
4
Equitable global access to coronavirus disease 2019 vaccines.2019冠状病毒病疫苗在全球的公平可及性。
BMJ. 2020 Dec 15;371:m4735. doi: 10.1136/bmj.m4735.
5
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.SARS-CoV-2 mRNA-1273疫苗接种后反应的持久性。
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
6
The International Health Regulations (2005), the threat of populism and the COVID-19 pandemic.《国际卫生条例（2005）》、民粹主义威胁与 COVID-19 大流行
Global Health. 2020 Jul 28;16(1):70. doi: 10.1186/s12992-020-00600-4.
7
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.非洲 COVID-19 大流行期间的常规儿童免疫接种：权衡 SARS-CoV-2 感染的超额风险与健康获益的利弊分析。
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272. doi: 10.1016/S2214-109X(20)30308-9. Epub 2020 Jul 17.
8
COVID-19 and routine childhood immunization in Africa: Leveraging systems thinking and implementation science to improve immunization system performance.非洲的新冠疫情与儿童常规免疫：利用系统思维和实施科学提高免疫系统绩效
Int J Infect Dis. 2020 Sep;98:161-165. doi: 10.1016/j.ijid.2020.06.072. Epub 2020 Jun 24.
9
Prevention of yellow fever in travellers: an update.旅行者黄热病预防：更新。
Lancet Infect Dis. 2020 Jun;20(6):e129-e137. doi: 10.1016/S1473-3099(20)30170-5. Epub 2020 May 7.
10
International travel between global urban centres vulnerable to yellow fever transmission.国际间往来于全球城市中心易传播黄热病。
Bull World Health Organ. 2018 May 1;96(5):343-354B. doi: 10.2471/BLT.17.205658. Epub 2018 Apr 11.
Zotero 插件